Better Therapeutics, Inc. (NASDAQ: BTTX) reported Q4 EPS of ($0.48), $0.03 worse than the analyst estimate of ($0.45). Revenue for the quarter came in at $0 versus the consensus estimate of $0 .

For earnings history and earnings-related data on Better Therapeutics, Inc. (BTTX) click here.